» Articles » PMID: 25940276

Knowledge-guided Docking: Accurate Prospective Prediction of Bound Configurations of Novel Ligands Using Surflex-Dock

Overview
Publisher Springer
Date 2015 May 6
PMID 25940276
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Prediction of the bound configuration of small-molecule ligands that differ substantially from the cognate ligand of a protein co-crystal structure is much more challenging than re-docking the cognate ligand. Success rates for cross-docking in the range of 20-30 % are common. We present an approach that uses structural information known prior to a particular cutoff-date to make predictions on ligands whose bounds structures were determined later. The knowledge-guided docking protocol was tested on a set of ten protein targets using a total of 949 ligands. The benchmark data set, called PINC ("PINC Is Not Cognate"), is publicly available. Protein pocket similarity was used to choose representative structures for ensemble-docking. The docking protocol made use of known ligand poses prior to the cutoff-date, both to help guide the configurational search and to adjust the rank of predicted poses. Overall, the top-scoring pose family was correct over 60 % of the time, with the top-two pose families approaching a 75 % success rate. Correct poses among all those predicted were identified nearly 90 % of the time. The largest improvements came from the use of molecular similarity to improve ligand pose rankings and the strategy for identifying representative protein structures. With the exception of a single outlier target, the knowledge-guided docking protocol produced results matching the quality of cognate-ligand re-docking, but it did so on a very challenging temporally-segregated cross-docking benchmark.

Citing Articles

Structure-based pose prediction: Non-cognate docking extended to macrocyclic ligands.

Cleves A, Tandon H, Jain A J Comput Aided Mol Des. 2024; 38(1):33.

PMID: 39414633 PMC: 11485047. DOI: 10.1007/s10822-024-00574-0.


Bridging Structure- and Ligand-Based Virtual Screening through Fragmented Interaction Fingerprint.

Syahdi R, Jasial S, Maeda I, Miyao T ACS Omega. 2024; 9(37):38957-38969.

PMID: 39310180 PMC: 11411525. DOI: 10.1021/acsomega.4c05433.


QSAR Study, Molecular Docking and Molecular Dynamic Simulation of Aurora Kinase Inhibitors Derived from Imidazo[4,5-]pyridine Derivatives.

Tian Y, Tong J, Liu Y, Tian Y Molecules. 2024; 29(8).

PMID: 38675594 PMC: 11052498. DOI: 10.3390/molecules29081772.


Novel Thiazolidinedione and Rhodanine Derivatives Regulate Glucose Metabolism, Improve Insulin Sensitivity, and Activate the Peroxisome Proliferator-Activated γ Receptor.

Al Neyadi S, Adem A, Amir N, Ghattas M, Abdou I, Salem A ACS Omega. 2024; 9(5):5463-5484.

PMID: 38343951 PMC: 10851269. DOI: 10.1021/acsomega.3c07149.


Cosolvent Sites-Based Discovery of Protein Kinase G Inhibitors.

Burastero O, Defelipe L, Gola G, Tateosian N, Lopez E, Martinena C J Med Chem. 2022; 65(14):9691-9705.

PMID: 35737472 PMC: 9344462. DOI: 10.1021/acs.jmedchem.1c02012.


References
1.
Spitzer R, Cleves A, Varela R, Jain A . Protein function annotation by local binding site surface similarity. Proteins. 2013; 82(4):679-94. PMC: 3949165. DOI: 10.1002/prot.24450. View

2.
Varela R, Cleves A, Spitzer R, Jain A . A structure-guided approach for protein pocket modeling and affinity prediction. J Comput Aided Mol Des. 2013; 27(11):917-34. PMC: 3851759. DOI: 10.1007/s10822-013-9688-9. View

3.
Friesner R, Banks J, Murphy R, Halgren T, Klicic J, Mainz D . Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem. 2004; 47(7):1739-49. DOI: 10.1021/jm0306430. View

4.
Berman H, Westbrook J, Feng Z, Gilliland G, Bhat T, Weissig H . The Protein Data Bank. Nucleic Acids Res. 1999; 28(1):235-42. PMC: 102472. DOI: 10.1093/nar/28.1.235. View

5.
Buolamwini J, Assefa H . CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site. J Med Chem. 2002; 45(4):841-52. DOI: 10.1021/jm010399h. View